Two new lignans from Dipteronia dyeriana | |
Guo, Rong1,2; Luo, Min3; Long, Chun Lin1; Li, Ma Lin3; Ouyang, Zhi Qin4; Zhou, Yi Ping3; Wang, Yue Hu1; Li, Xing Yu1,2; Shi, Ya Na1,2 | |
通讯作者 | long@mail.kib.ac.cn ; limalinb@vip.163.com |
2008-10-01 | |
发表期刊 | CHINESE CHEMICAL LETTERS |
ISSN | 1001-8417 |
卷号 | 19期号:10页码:1215-1217 |
摘要 | A new sesquilignan, 70,80-didehydroherpetotriol (1), and a new lignan glycoside, (+)-isolariciresinol-9'-O-alpha-L-rhamnopyranosyl-(1 -> 6)-beta-D- glucopyranoside (2), were isolated from the branches of Dipteronia dyeriana. Their structures were elucidated by spectroscopic methods and chemical evidence. Compound 1 possessed inhibitory activity against human leukaemia K562 cells with an IC(50) value of 39 mu mol/L. (C) 2008 Chun Lin Long. Published by Elsevier B. V. on behalf of Chinese Chemical Society. All rights reserved. |
关键词 | Aceraceae Dipteronia Dyeriana Lignans Didehydroherpetotriol Leukaemia |
学科领域 | Chemistry, Multidisciplinary |
DOI | 10.1016/j.cclet.2008.06.051 |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000263669300022 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.kib.ac.cn/handle/151853/2473 |
专题 | 资源植物与生物技术所级重点实验室 |
作者单位 | 1.Chinese Acad Sci, Kunming Inst Bot, Kunming 650204, Peoples R China 2.Yunnan Agr Univ, Kunming 650201, Peoples R China 3.Kunming Med Coll, Yunnan Lab Pharmacol Nat Prod, Kunming 650031, Peoples R China 4.Yunnan Intro & Propagat Ctr Rare & Endangered Pla, Kunming 650032, Peoples R China |
推荐引用方式 GB/T 7714 | Guo, Rong,Luo, Min,Long, Chun Lin,et al. Two new lignans from Dipteronia dyeriana[J]. CHINESE CHEMICAL LETTERS,2008,19(10):1215-1217. |
APA | Guo, Rong.,Luo, Min.,Long, Chun Lin.,Li, Ma Lin.,Ouyang, Zhi Qin.,...&Shi, Ya Na.(2008).Two new lignans from Dipteronia dyeriana.CHINESE CHEMICAL LETTERS,19(10),1215-1217. |
MLA | Guo, Rong,et al."Two new lignans from Dipteronia dyeriana".CHINESE CHEMICAL LETTERS 19.10(2008):1215-1217. |
条目包含的文件 | 下载所有文件 | |||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
201111010007.pdf(158KB) | 开放获取 | -- | 浏览 下载 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论